Retrospective chart review on psychiatric manifestations of GLP-1 agonist usage

Key Points

• Psychiatric manifestations linked to GLP-1 agonists include anxiety and depression, showing a clear impact on mental health.
• Review of patient charts revealed significant psychiatric symptoms in 30% of those on GLP-1 agonists.
• Retrospective chart review across multiple clinics identified various medication effects on mental health and neurobiology.
• Findings support the need for further study on the psychiatric implications of GLP-1 agonist treatments.